As we have not investigated a potential impact of i.n. IFN-β treatment on pneumonia outcome in this study, future research will be required to assess potential consequences of exogenous IFN-β administration on pneumococcal clearance. Here, IFNB1 is linked to susceptibility to pneumonia measurement.